ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $789,964 | +19.7% | 13,606 | +11.0% | 0.01% | +33.3% |
| Q2 2023 | $659,902 | +51.6% | 12,259 | +11.9% | 0.01% | +50.0% |
| Q1 2023 | $435,212 | +131782.4% | 10,957 | +33.4% | 0.00% | -20.0% |
| Q4 2022 | $330 | -99.9% | 8,214 | -5.4% | 0.01% | +25.0% |
| Q3 2022 | $279,000 | +0.4% | 8,683 | -7.3% | 0.00% | 0.0% |
| Q2 2022 | $278,000 | +9.4% | 9,371 | +3.9% | 0.00% | +33.3% |
| Q1 2022 | $254,000 | -29.4% | 9,021 | +15.6% | 0.00% | -25.0% |
| Q4 2021 | $360,000 | +53.2% | 7,807 | +8.9% | 0.00% | +33.3% |
| Q3 2021 | $235,000 | -9.3% | 7,169 | -3.1% | 0.00% | 0.0% |
| Q2 2021 | $259,000 | -0.4% | 7,399 | +2.8% | 0.00% | 0.0% |
| Q1 2021 | $260,000 | +15.6% | 7,196 | -7.0% | 0.00% | 0.0% |
| Q4 2020 | $225,000 | -11.1% | 7,734 | -13.6% | 0.00% | 0.0% |
| Q3 2020 | $253,000 | +4.1% | 8,954 | +19.4% | 0.00% | -25.0% |
| Q2 2020 | $243,000 | -24.1% | 7,501 | -4.5% | 0.00% | -33.3% |
| Q1 2020 | $320,000 | -18.4% | 7,852 | +23.4% | 0.01% | 0.0% |
| Q4 2019 | $392,000 | -15.0% | 6,362 | +0.5% | 0.01% | -14.3% |
| Q3 2019 | $461,000 | -1.9% | 6,328 | +10.7% | 0.01% | 0.0% |
| Q2 2019 | $470,000 | +18.4% | 5,718 | +1.5% | 0.01% | +16.7% |
| Q1 2019 | $397,000 | +62.7% | 5,633 | +3.8% | 0.01% | +50.0% |
| Q4 2018 | $244,000 | -17.0% | 5,427 | +4.3% | 0.00% | 0.0% |
| Q3 2018 | $294,000 | -24.8% | 5,205 | -11.1% | 0.00% | -20.0% |
| Q2 2018 | $391,000 | +13.3% | 5,857 | -1.3% | 0.01% | 0.0% |
| Q1 2018 | $345,000 | -11.5% | 5,933 | -2.0% | 0.01% | 0.0% |
| Q4 2017 | $390,000 | +13.7% | 6,057 | -7.4% | 0.01% | +25.0% |
| Q3 2017 | $343,000 | +25.2% | 6,542 | +11.6% | 0.00% | 0.0% |
| Q2 2017 | $274,000 | -3.9% | 5,863 | +1.9% | 0.00% | 0.0% |
| Q1 2017 | $285,000 | -19.3% | 5,752 | -1.3% | 0.00% | -20.0% |
| Q4 2016 | $353,000 | -12.2% | 5,828 | -3.7% | 0.01% | 0.0% |
| Q3 2016 | $402,000 | +24.1% | 6,052 | +4.3% | 0.01% | +25.0% |
| Q2 2016 | $324,000 | +58.8% | 5,800 | -4.1% | 0.00% | +33.3% |
| Q1 2016 | $204,000 | -27.9% | 6,050 | -3.7% | 0.00% | 0.0% |
| Q4 2015 | $283,000 | +14.6% | 6,282 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $247,000 | -43.1% | 6,248 | -10.6% | 0.00% | -40.0% |
| Q2 2015 | $434,000 | -6.1% | 6,992 | -5.3% | 0.01% | 0.0% |
| Q1 2015 | $462,000 | – | 7,385 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 328,494 | $15,137,000 | 4.72% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $13,824,000 | 2.78% |
| Mesirow Financial Investment Management, Inc. | 12,277 | $566,000 | 1.63% |
| Parkman Healthcare Partners LLC | 137,226 | $6,323,000 | 1.40% |
| Global Alpha Capital Management Ltd. | 284,831 | $13,125,000 | 1.27% |
| Stonepine Capital Management, LLC | 52,290 | $2,410,000 | 1.11% |
| 1492 Capital Management LLC | 43,611 | $2,010,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,770 | $3,445,000 | 0.81% |
| Walthausen & Co., LLC | 61,456 | $2,832,000 | 0.74% |
| Rubric Capital Management LP | 307,557 | $14,172,000 | 0.67% |